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Introduction: Medulloblastoma is one of the most common pediatric brain malignancies. The usual presenting
clinical features are related to posterior fossa syndrome or/and hydrocephalus. Cauda equina syndrome is a very
rare presentation for this disease.
Case presentation: We describe the case of a three-year-old boy with cauda equina syndrome as the initial
presenting clinical feature for medulloblastoma. He was initially diagnosed as having a spinal tumor by magnetic
resonance imaging scan. Subsequently, a cranial magnetic resonance imaging scan revealed a posterior fossa tumor
with features of dissemination. He had substantial improvement after treatment. This case report is complemented
by a literature review related to this unusual presentation.
Conclusions: Medulloblastoma primarily presenting with cauda equina syndrome is very rare. However, spinal drop
metastasis should be considered in the pediatric age group to avoid suboptimal management.
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Medulloblastoma is the second most common posterior
fossa tumor in children. It accounts for 40% of posterior
fossa tumors in the pediatric age group [1]. The clinical
presentation of this malignant tumor is usually related
to the posterior fossa tumor mass effect and/or obstruct-
ive hydrocephalus. Cerebrospinal fluid (CSF) dissemin-
ation to the cranio-spinal axis occurs in 30% to 40% of
cases [2]. However, medulloblastoma primarily present-
ing with symptoms related to spinal metastasis is ex-
tremely rare [2,3]. To date, there are only a limited
number of cases that have been reported in the litera-
ture. Here, we report the case of a child with medullo-
blastoma who presented with progressive paraparesis
caused by cauda equina drop metastasis without symp-
toms related to the primary intracranial tumor.
Case presentation
Our patient was a three-year-old Arabic boy who pre-
sented to a peripheral medical center with a two-month
history of lower back pain followed by progressive* Correspondence: faisalruwais@gmail.com
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reproduction in any medium, provided the orparaparesis. He had no symptomatology related to pos-
terior fossa syndrome or increased intracranial pressure.
Six weeks after the start of his symptoms, he developed
urinary and bowel incontinence. During the physical
examination, the boy was fully awake and cooperative.
All cranial nerves were intact. His pupils were 2 mm, bi-
laterally equal and normally reacting to light. He had full
extra-ocular movement with no nystagmus. There was
no papilloedema. An examination of the upper extrem-
ities was normal. He had symmetrical lower limb weak-
ness with muscle group power grade 1/5 distally and 3/5
proximally associated with hypotonia, absent reflexes
and diminished sensations up to the L1 dermatome. His
anal tone was reduced. Cauda equina syndrome was sus-
pected, for which he underwent a magnetic resonance
imaging (MRI) scan of the spine that revealed spinal
canal filling and lesions in the thoracic and lumbar
regions. At that stage, he was referred to our institution
as a patient with a spinal tumor.
Upon reviewing his spinal MRI, drop metastasis was
suspected. A cranio-spinal MRI scan was performed,
which showed a posterior fossa tumor associated with
radiographic features of intracranial and spinal metasta-
sis, (Figures 1A, B and 2A). This MRI feature was sug-
gestive of medulloblastoma. Given the fact that theal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 (A) Axial magnetic resonance imaging T1-weighted image with gadolinium, showing a posterior fossa tumor. (B) Sagittal
magnetic resonance imaging T1-weighted image with gadolinium showing posterior fossa tumor (arrow) and frontobasal tumor (arrowhead),
suggestive of cerebrospinal fluid (CSF) metastasis. (C,D) Post-treatment, one-year follow-up axial and sagittal magnetic resonance imaging
revealed regression of the disease.
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affecting cauda equina roots, which is probably not
amenable to surgical removal, we decided to direct the
surgical treatment to the primary posterior fossa tumor
only. Therefore, he underwent a suboccipital craniotomy
and subtotal resection of the posterior fossa tumor.
Neuropathological examination of the resected specimen
revealed features of classic medulloblastoma. The cells
had primitive nuclei, which were packed without signs
of differentiation (Figure 3A). Also, the tumor lacked
any anaplastic or large cell features. The tumor cells
were uniformly expressing synaptophysin (Novocastra™,
clone 27 G12, 1:100, Newcastle, UK) (Figure 3B). Since
our patient was young and the clinical course was atyp-
ical, immunostaining for integrase interactor 1 (INI-1)
protein (BAF47; BD Biosciences, clone 25, 1:200) was
also performed and the neoplastic cells were uniformly
immunoreactive to it (Figure 3C). This practically
excludes atypical teratoid/rhabdoid tumor as a diagnos-
tic possibility. Subsequently, our patient received cranio-
spinal axis radiotherapy (36 Gy) and 18 Gy boost to the
posterior fossa. Adjunctive chemotherapy was given,which consisted of vincristine, cisplatin, and CCNU
(lomustine).
During his treatment course he received rehabilitation
therapy. Three months after his initial treatment, he had
substantial improvement in his overall neurological
functions. He started to walk without assistance and was
able to control his bladder and bowel functions. A neu-
roaxis follow-up MRI after one year showed regression
of his cranial and spinal disease (Figures 1C, D and 2B).
At the time of writing this report, he has retained good
neurological function.
Discussion
The usual presenting symptoms of medulloblastoma are
headache, vomiting and ataxia [2,4]. Although CSF dis-
semination to the cranio-spinal axis can happen in 30%
to 40% of cases, initial presentation with spinal cord
compression is quite rare [1,2,5]. Pezeshkpour and col-
leagues analyzed more than 18,000 primary central ner-
vous system tumors and found that only 0.01% of them
had drop spinal metastasis, which had caused the pre-
senting symptoms [6]. At the time of diagnosis around
Figure 2 (A) Pre-treatment spinal T1-weighted image with
gadolinium demonstrating a nodular extra-medullary
enhancement (arrowhead) and spinal block in the lumbar
region (arrow). (B) Post-treatment one-year follow-up spinal
magnetic resonance imaging revealed regression of the disease.
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metastasis, however, their main presenting symptoms
were due to the primary intracranial tumor [3]. In 1986,
Wang et al., reported the case of a 28-year-old woman
with thoracic extra-medullary medulloblastoma metasta-
sis causing her to have progressive weakness as the ini-
tial presenting symptoms (Table 1) [7]. More recently,
Lee and colleagues from China described a case with
acute paraplegia caused by drop spinal metastasis [8].
Stanley and colleagues, in 1988, reported on 34 patients
with medulloblastoma [5]. Fifteen of those had a positive
result on myelogram for spinal metastasis and only one
patient suffered from lower limb weakness related to
spinal pathology; however, it was not the initial present-
ing symptom. Our group, in 1996, reported on the out-
comes of 149 patients who received treatment at ourinstitution. None of those had presented initially with
symptoms related to spinal metastasis at time of diagnosis
[9]. Two adult patients have been reported in non-English
language articles: one with cauda equine syndrome and
the other with radiculitis features as the presenting clinical
features of medulloblastoma [10,11].
However, spinal intramedullary metastasis of medullo-
blastoma rarely occurs. To date, there have been a limited
number of cases with spinal intramedullary metastasis
reported in the literature [12-14]. Zumpano, in 1978,
reported on a patient with intramedullary metastatic
medulloblastoma several weeks after resecting the poster-
ior fossa tumor [12]. Subsequently, a similar case was
described by Stanley et al. in 1986 [5]. Recently, Inoue and
colleagues reported on a child who had progressive weak-
ness as the initial presenting features for intramedullary
spinal metastasis [14]. In general, medulloblastoma spinal
metastasis varied from nodular lesions to complete spinal
block [5]. Our patient had extramedullary nodules, lepto-
meningeal enhancement and spinal block at the lumbar
region. The cranial MRI findings were of sufficient im-
portance to alter the management of our patient and to
pave the way for different treatment strategies.Conclusions
Cauda equina syndrome as the presenting clinical fea-
ture for medulloblastoma is rare. Similar clinical presen-
tations in the pediatric age group should raise the
suspicion of cranial neoplastic pathology. Cranial neuroi-
maging is important to rule out drop metastasis and to
optimize patient management.Consent
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Figure 3 Morphology of classic medulloblastoma as shown in (A) (hematoxylin and eosin stain; original magnification, 200×) with
strong and uniform expression of synaptophysin (B) (Novocastra™, clone 27 G12, 1:100; original magnification, 200×) and BAF47 (C)
(BD Biosciences, clone 25, 1:200; original magnification, 200×).
Table 1 Selected reported cases of cauda equine syndrome as the main initial presenting clinical features
Author (year) and reference Age Gender Clinical presentation
Wang [7] 28 years Male Progressive lower limb weakness
Alla [11] (article in French) 64 years Male Radiculitis features followed by cauda equina syndrome features
Lee [8] 4 years Female Cauda equina syndrome features (lower limb weakness and urinary retention)
Present case report 3 years Male Cauda equina syndrome features
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